北(bei)京2024年9月23日 /美通(tong)(tong)社/ -- 總部位(wei)(wei)于中國北京(jing)的(de)(de)(de)(de)(de)在(zai)線(xian)營銷解決(jue)方案提供商浩(hao)希(xi)健康科技(ji)有限公(gong)司(si)（"公(gong)司(si)"或(huo)"HAO"）今日宣(xuan)布(bu)完成其4,000,000份(fen)(fen)(fen)單位(wei)(wei)（"單位(wei)(wei)"），發(fa)(fa)行(xing)(xing)價格為(wei)(wei)(wei)每單位(wei)(wei)3美元(yuan)(yuan)（"公(gong)開發(fa)(fa)行(xing)(xing)價格"）的(de)(de)(de)(de)(de)公(gong)募(mu)再(zai)融資(zi)發(fa)(fa)行(xing)(xing)（"發(fa)(fa)行(xing)(xing)"）。每份(fen)(fen)(fen)發(fa)(fa)行(xing)(xing)單位(wei)(wei)包(bao)括：（i）一(yi)(yi)股(gu)(gu)(gu)(gu)面值為(wei)(wei)(wei)0.0001美元(yuan)(yuan)/股(gu)(gu)(gu)(gu)的(de)(de)(de)(de)(de)A類(lei)(lei)普通(tong)(tong)股(gu)(gu)(gu)(gu)（"A類(lei)(lei)普通(tong)(tong)股(gu)(gu)(gu)(gu)"）（或(huo)一(yi)(yi)份(fen)(fen)(fen)預(yu)先融資(zi)的(de)(de)(de)(de)(de)購買一(yi)(yi)股(gu)(gu)(gu)(gu)A類(lei)(lei)普通(tong)(tong)股(gu)(gu)(gu)(gu)的(de)(de)(de)(de)(de)認(ren)(ren)股(gu)(gu)(gu)(gu)權(quan)(quan)(quan)(quan)證(zheng)（"預(yu)先融資(zi)認(ren)(ren)股(gu)(gu)(gu)(gu)權(quan)(quan)(quan)(quan)證(zheng)"））；（ii）一(yi)(yi)份(fen)(fen)(fen)購買一(yi)(yi)股(gu)(gu)(gu)(gu)A類(lei)(lei)普通(tong)(tong)股(gu)(gu)(gu)(gu)的(de)(de)(de)(de)(de)A系(xi)列認(ren)(ren)股(gu)(gu)(gu)(gu)權(quan)(quan)(quan)(quan)證(zheng)（"A系(xi)列認(ren)(ren)股(gu)(gu)(gu)(gu)權(quan)(quan)(quan)(quan)證(zheng)"），但在(zai)B系(xi)列行(xing)(xing)權(quan)(quan)(quan)(quan)日期之(zhi)后為(wei)(wei)(wei)購買五股(gu)(gu)(gu)(gu)A類(lei)(lei)普通(tong)(tong)股(gu)(gu)(gu)(gu)；以(yi)及(ji)（iii）一(yi)(yi)張(zhang)在(zai)B系(xi)列行(xing)(xing)使日期之(zhi)后的(de)(de)(de)(de)(de)第十六(liu)（16）個日歷日（"B系(xi)列行(xing)(xing)權(quan)(quan)(quan)(quan)日"）起購買四股(gu)(gu)(gu)(gu)A類(lei)(lei)普通(tong)(tong)股(gu)(gu)(gu)(gu)的(de)(de)(de)(de)(de)B系(xi)列認(ren)(ren)股(gu)(gu)(gu)(gu)權(quan)(quan)(quan)(quan)證(zheng)（"B系(xi)列認(ren)(ren)股(gu)(gu)(gu)(gu)權(quan)(quan)(quan)(quan)證(zheng)"，與"A系(xi)列認(ren)(ren)股(gu)(gu)(gu)(gu)權(quan)(quan)(quan)(quan)證(zheng)"合(he)稱為(wei)(wei)(wei)"認(ren)(ren)股(gu)(gu)(gu)(gu)權(quan)(quan)(quan)(quan)證(zheng)"）。 單位(wei)(wei)不(bu)具(ju)有獨(du)立(li)權(quan)(quan)(quan)(quan)利，因此(ci)不(bu)是單獨(du)的(de)(de)(de)(de)(de)證(zheng)券，也不(bu)以(yi)單獨(du)的(de)(de)(de)(de)(de)證(zheng)券形式發(fa)(fa)行(xing)(xing)。 A類(lei)(lei)普通(tong)(tong)股(gu)(gu)(gu)(gu)和相關的(de)(de)(de)(de)(de)認(ren)(ren)股(gu)(gu)(gu)(gu)權(quan)(quan)(quan)(quan)證(zheng)在(zai)發(fa)(fa)行(xing)(xing)中分別單獨(du)發(fa)(fa)行(xing)(xing)。在(zai)未扣除承銷折扣和其他發(fa)(fa)行(xing)(xing)費用(yong)，及(ji)不(bu)包(bao)含認(ren)(ren)股(gu)(gu)(gu)(gu)權(quan)(quan)(quan)(quan)證(zheng)行(xing)(xing)權(quan)(quan)(quan)(quan)的(de)(de)(de)(de)(de)情況(kuang)下，本次公(gong)募(mu)再(zai)融資(zi)發(fa)(fa)行(xing)(xing)的(de)(de)(de)(de)(de)募(mu)資(zi)所得為(wei)(wei)(wei)1200萬美元(yuan)(yuan)。

本次發(fa)行(xing)采用(yong)包銷方式進行(xing)。公(gong)司已授予主承銷商EF Hutton LLC（EF Hutton）可在發(fa)行(xing)交割日(ri)后45天內(nei)以公(gong)開發(fa)行(xing)價格（扣除(chu)承銷折扣）額外(wai)認購60萬單位(wei)，以覆(fu)蓋(gai)超額配售權(quan)。

EF Hutton擔任本次發行的(de)(de)唯一賬簿管(guan)理人。Hunter Taubman Fischer & Li LLC擔任公司(si)的(de)(de)美國法(fa)律顧問，Pryor Cashman LLP擔任EF Hutton與本次發行有關的(de)(de)美國法(fa)律顧問。

"我們(men)很高興完成(cheng)此次再融資發行(xing)(xing)，感(gan)謝(xie)投資者(zhe)對(dui)我們(men)執(zhi)行(xing)(xing)業務(wu)計劃的(de)持(chi)(chi)續(xu)支持(chi)(chi)和認可。"HAO的(de)董事(shi)長兼首席執(zhi)行(xing)(xing)官樊震先生表示(shi)。"此次募集的(de)資金(jin)將有(you)助于(yu)我們(men)繼續(xu)擴大業務(wu)規模，并(bing)在醫療保(bao)健行(xing)(xing)業進行(xing)(xing)潛(qian)在技術投資。"

與本次(ci)發行有關(guan)的(de)注冊聲(sheng)明（Form F-1，文件號）經(jing)修(xiu)訂后(hou)已(yi)向美國(guo)證券(quan)交(jiao)易委員(yuan)會（SEC）提交(jiao)，并于(yu)2024年9月19日獲(huo)(huo)SEC批準生效。本次(ci)發行僅通(tong)過招(zhao)股(gu)(gu)說明書進行。有關(guan)此(ci)次(ci)發行的(de)最終招(zhao)股(gu)(gu)說明書的(de)副(fu)本可(ke)從EF Hutton處(chu)獲(huo)(huo)得，地址(zhi)為紐約市(shi)麥迪遜大道590號39樓(Attn: Syndicate Department)(212) 404-7002. 此(ci)外，最終招(zhao)股(gu)(gu)章(zhang)程的(de)副(fu)本也可(ke)通(tong)過SEC的(de)網站www.sec.gov獲(huo)(huo)得。

于投資(zi)前，閣下應閱讀招股說(shuo)明書及本公司(si)已提交或(huo)將(jiang)向SEC提交的(de)(de)其他文件，以了解有關本公司(si)及發售(shou)的(de)(de)更多資(zi)料。本新聞(wen)稿不構成出(chu)售(shou)或(huo)征集(ji)購買本報告所述(shu)證券(quan)(quan)(quan)的(de)(de)要約，也不構成在根據任何(he)該(gai)等(deng)州(zhou)或(huo)司(si)法(fa)管轄區(qu)的(de)(de)證券(quan)(quan)(quan)法(fa)進行登記或(huo)資(zi)格之前，在該(gai)等(deng)要約、征集(ji)或(huo)出(chu)售(shou)將(jiang)屬非法(fa)的(de)(de)任何(he)州(zhou)或(huo)司(si)法(fa)管轄區(qu)出(chu)售(shou)該(gai)等(deng)證券(quan)(quan)(quan)。

關于浩希健康科技有限公司

浩(hao)希健康科技有限公(gong)司(si)是(shi)一家總部(bu)位(wei)于北京的(de)(de)中國在(zai)(zai)線(xian)營(ying)(ying)銷(xiao)(xiao)(xiao)解決(jue)方(fang)案提(ti)供(gong)商(shang)，專門為醫療保健行(xing)(xing)業(ye)的(de)(de)客戶(hu)提(ti)供(gong)廣告(gao)服務。該(gai)公(gong)司(si)的(de)(de)增長是(shi)由新聞推(tui)送廣告(gao)的(de)(de)崛(jue)起和(he)醫療保健行(xing)(xing)業(ye)的(de)(de)快(kuai)速發展推(tui)動的(de)(de)。該(gai)公(gong)司(si)提(ti)供(gong)一站式(shi)在(zai)(zai)線(xian)營(ying)(ying)銷(xiao)(xiao)(xiao)解決(jue)方(fang)案，特別(bie)是(shi)在(zai)(zai)在(zai)(zai)線(xian)短視頻營(ying)(ying)銷(xiao)(xiao)(xiao)方(fang)面，幫助廣告(gao)商(shang)在(zai)(zai)今(jin)日頭(tou)條、抖音、微信和(he)新浪(lang)微博等中國流行(xing)(xing)平臺(tai)上獲(huo)取和(he)留存客戶(hu)。它致(zhi)力(li)于降低成本，提(ti)高效(xiao)率，并為廣告(gao)商(shang)提(ti)供(gong)簡(jian)單的(de)(de)在(zai)(zai)線(xian)營(ying)(ying)銷(xiao)(xiao)(xiao)解決(jue)方(fang)案。欲了解更(geng)多信息(xi)，請訪問。

前瞻性聲明

本(ben)新聞稿(gao)載有(you)(you)前(qian)(qian)瞻(zhan)(zhan)性(xing)(xing)聲(sheng)(sheng)(sheng)(sheng)明(ming)。前(qian)(qian)瞻(zhan)(zhan)性(xing)(xing)陳(chen)(chen)述(shu)包(bao)括有(you)(you)關計(ji)(ji)劃、目標、目標、策略(lve)、未(wei)來(lai)事(shi)件(jian)或表(biao)現(xian)的(de)(de)(de)(de)陳(chen)(chen)述(shu)，以及(ji)相關假(jia)設(she)及(ji)其(qi)(qi)他陳(chen)(chen)述(shu)(歷(li)史(shi)事(shi)實(shi)陳(chen)(chen)述(shu)除外)。當(dang)本(ben)公(gong)司(si)(si)使(shi)用"可能"、"將"、"有(you)(you)意"、"應"、"相信"、"預期(qi)(qi)"、"項目"、"估計(ji)(ji)"或類似表(biao)述(shu)(并(bing)非僅與歷(li)史(shi)事(shi)項有(you)(you)關)，則其(qi)(qi)作(zuo)出前(qian)(qian)瞻(zhan)(zhan)性(xing)(xing)陳(chen)(chen)述(shu)。該(gai)等(deng)前(qian)(qian)瞻(zhan)(zhan)性(xing)(xing)聲(sheng)(sheng)(sheng)(sheng)明(ming)包(bao)括但(dan)不(bu)限于(yu)(yu)本(ben)公(gong)司(si)(si)有(you)(you)關其(qi)(qi)普通股(gu)于(yu)(yu)納斯達克資本(ben)市場的(de)(de)(de)(de)預期(qi)(qi)交易及(ji)發(fa)售結束的(de)(de)(de)(de)聲(sheng)(sheng)(sheng)(sheng)明(ming)。前(qian)(qian)瞻(zhan)(zhan)性(xing)(xing)陳(chen)(chen)述(shu)并(bing)非對未(wei)來(lai)表(biao)現(xian)的(de)(de)(de)(de)保證，并(bing)涉及(ji)可能導致實(shi)際業績(ji)與前(qian)(qian)瞻(zhan)(zhan)性(xing)(xing)陳(chen)(chen)述(shu)所討論(lun)(lun)的(de)(de)(de)(de)本(ben)公(gong)司(si)(si)預期(qi)(qi)有(you)(you)重大差異的(de)(de)(de)(de)風險(xian)及(ji)不(bu)確定(ding)因(yin)(yin)素(su)(su)。該(gai)等(deng)聲(sheng)(sheng)(sheng)(sheng)明(ming)受(shou)限于(yu)(yu)不(bu)確定(ding)性(xing)(xing)及(ji)風險(xian)，包(bao)括但(dan)不(bu)限于(yu)(yu)與市況及(ji)按預期(qi)(qi)條款或根本(ben)完成首次公(gong)開發(fa)售有(you)(you)關的(de)(de)(de)(de)不(bu)確定(ding)性(xing)(xing)，以及(ji)向(xiang)SEC提(ti)交的(de)(de)(de)(de)注冊(ce)聲(sheng)(sheng)(sheng)(sheng)明(ming)"風險(xian)因(yin)(yin)素(su)(su)"一節(jie)所討論(lun)(lun)的(de)(de)(de)(de)其(qi)(qi)他因(yin)(yin)素(su)(su)。出于(yu)(yu)該(gai)等(deng)原因(yin)(yin)，(其(qi)(qi)中(zhong)包(bao)括)提(ti)醒(xing)投資者不(bu)要過(guo)度(du)依賴(lai)本(ben)新聞稿(gao)中(zhong)的(de)(de)(de)(de)任何前(qian)(qian)瞻(zhan)(zhan)性(xing)(xing)聲(sheng)(sheng)(sheng)(sheng)明(ming)。其(qi)(qi)他因(yin)(yin)素(su)(su)在(zai)(zai)該(gai)公(gong)司(si)(si)向(xiang)SEC提(ti)交的(de)(de)(de)(de)文件(jian)中(zhong)討論(lun)(lun)，這些(xie)文件(jian)可在(zai)(zai)www.sec.gov上查(cha)閱(yue)。本(ben)公(gong)司(si)(si)并(bing)無義務公(gong)開修訂該(gai)等(deng)前(qian)(qian)瞻(zhan)(zhan)性(xing)(xing)陳(chen)(chen)述(shu)，以反映本(ben)報告日(ri)期(qi)(qi)后(hou)發(fa)生的(de)(de)(de)(de)事(shi)件(jian)或情況。

更多詳情請垂詢:

承銷商
EF Hutton LLC
Ms. Stephanie Hu, Head of Asia, Investment Banking
Email：  

投資者關系

WFS Investor Relations Inc.
Janice Wang, Managing Partner
Email:
Phone: +86
+1 628 283 9214